Sysmex

Sysmex Net Change in Cash

The Net Change in Cash of Sysmex (6869.T) as of Oct 20, 2026 is -5.45 B JPY. In the previous year, Net Change in Cash was 14.06 B JPY — a change of -138.78% (lower).

Net Change in Cash

-5.45 BJPY

YoY

-138.78%

Last updated:

Net Change in Cash of Sysmex is 2026 -5.45 B JPY. Net Change in Cash of Sysmex was 2025 14.06 B JPY. It decreases by -138.78% lower compared to the previous year.

The Sysmex Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2019
-10.38 B JPY
Jan 1, 2020
5.53 B JPY
Jan 1, 2021
9.88 B JPY
Jan 1, 2022
7.29 B JPY
Jan 1, 2023
-4.29 B JPY
Jan 1, 2024
6.05 B JPY
Jan 1, 2025
14.06 B JPY
Jan 1, 2026
-5.45 B JPY
The Sysmex Net Change in Cash history
YEARNet Change in CashYoY
-5.45 BJPY-138.78%
14.06 BJPY+132.56%
6.05 BJPY-240.89%
-4.29 BJPY-158.92%
7.29 BJPY-26.23%
9.88 BJPY+78.57%
5.53 BJPY-153.27%
-10.38 BJPY-396.63%
3.50 BJPY+139.23%
1.46 BJPY-76.44%
6.21 BJPY-54.26%
13.57 BJPY+373.29%
2.87 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sysmex Stock analysis

What does Sysmex do? Sysmex Corp is a Japanese company that has been a leading provider of diagnostic and analytical laboratory systems and solutions for the healthcare industry since its founding in 1968. The company is headquartered in Kobe, Japan and employs over 9,000 people worldwide. History: Sysmex was founded by a group of young scientists in Japan who wanted to develop an automated blood cell analysis system to improve the high workload of manual blood analysis at the time. The company began developing this system and brought it to market in 1972. Business model: Sysmex focuses on the development, production, and sale of diagnostic systems and solutions for medical laboratories around the world. The company specializes in hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology. Divisions: Sysmex Corp is divided into three main business divisions: 1. Diagnostic Systems: This division includes hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology systems. Sysmex is one of the world's leading providers of hematology analysis devices and also offers molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. 2. Information Solutions: This division offers software and IT solutions that support laboratory management and the integration of laboratory data to optimize analysis processes. The company also offers solutions for automating laboratory processes and managing laboratory inventory. 3. Life Science: This division focuses on the development of products for the life sciences, particularly cell analysis and imaging, as well as production, processing, and storage of cell cultures. Sysmex is also involved in the production of devices for harvesting mesenchymal stem cells from adipose tissue. Products: Sysmex offers a variety of products, including: - Hematology analysis devices for determining blood cell parameters such as RBC, WBC, HGB, HCT, and platelets. - Hemostasis systems for analyzing blood coagulation. - Molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. - Urinalysis systems for analyzing urine samples for chemical and microscopic parameters. - Immunology analysis devices for determining specific proteins and antibodies in the blood. - Clinical chemistry analysis devices for analyzing chemical parameters in blood samples. - Software and IT solutions for optimizing laboratory processes and management. - Cell analysis and imaging systems for investigating cell morphology and functions. - Devices for harvesting mesenchymal stem cells from adipose tissue. In summary, Sysmex Corp is a global leader in diagnostic and analytical laboratory systems and solutions for the healthcare industry. In its nearly 50-year history, the company has developed and produced a wide range of products that enable laboratories to perform fast and accurate disease diagnosis. The company has also expanded its business into other areas such as information solutions and the life sciences. Sysmex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sysmex stock

Net Change in Cash of Sysmex is -5.45 B JPY in 2026.

Net Change in Cash of Sysmex changed from 14.06 B JPY to -5.45 B JPY, representing a -138.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Sysmex since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Sysmex historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Sysmex

All Key Metrics — Sysmex